Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SOHO
3276
DELISTED
Sotherly Hotels
SOHO
| $2.74M | ﹤0.01% |
359,430
+17,639
| +5% | +$133K |
|
3277
First Business Financial Services
FBIZ
$603M
| $2.73M | ﹤0.01% |
126,132
+8,644
| +7% | +$196K |
|
|
SCX
3278
DELISTED
The L.S. Starrett Company
SCX
| $2.72M | ﹤0.01% |
143,201
+16,049
| +13% | +$329K |
|
3279
Aviat Networks
AVNW
$272M
| $2.71M | ﹤0.01% |
379,023
+8,480
| +2% | +$66.4K |
|
|
AMRS
3280
DELISTED
Amyris Inc.
AMRS
| $2.71M | ﹤0.01% |
75,142
+3,381
| +5% | +$108K |
|
|
CNXR
3281
DELISTED
Connecture, Inc.
CNXR
| $2.7M | ﹤0.01% |
+260,915
| New | +$2.41M |
|
|
TTOO
3282
DELISTED
T2 Biosystems, Inc
TTOO
| $2.69M | ﹤0.01% |
35
+4
| +13% | +$371K |
|
|
YDLE
3283
DELISTED
YODLEE INC COMMON STOCK
YDLE
| $2.69M | ﹤0.01% |
199,636
+106,164
| +114% | +$1.25M |
|
3284
Townsquare Media
TSQ
$114M
| $2.68M | ﹤0.01% |
208,796
+18,516
| +10% | +$241K |
|
|
EXA
3285
DELISTED
EXA Corporation
EXA
| $2.67M | ﹤0.01% |
224,739
+44,800
| +25% | +$474K |
|
|
KIN
3286
DELISTED
Kindred Biosciences, Inc.
KIN
| $2.66M | ﹤0.01% |
372,801
+37,881
| +11% | +$261K |
|
|
IHC
3287
DELISTED
Independence Holding Company
IHC
| $2.66M | ﹤0.01% |
195,762
+778
| +0.4% | +$9.97K |
|
3288
NanoViricides
NNVC
$35.7M
| $2.65M | ﹤0.01% |
59,005
+3,477
| +6% | +$185K |
|
|
FCSC
3289
DELISTED
Fibrocell Science Inc.
FCSC
| $2.65M | ﹤0.01% |
39,231
+3,030
| +8% | +$195K |
|
|
CHL
3290
DELISTED
China Mobile Limited
CHL
| $2.65M | ﹤0.01% |
40,800
+16,100
| +65% | +$1.05M |
|
|
NVO
3291
Novo Nordisk
NVO
$203B
| $2.65M | ﹤0.01% |
+99,200
| New | +$2.28M |
|
|
APP
3292
DELISTED
AMERICAN APPAREL INC COM
APP
| $2.64M | ﹤0.01% |
3,760,322
+322,814
| +9% | +$271K |
|
3293
Altimmune
ALT
$585M
| $2.62M | ﹤0.01% |
5,347
+43
| +0.8% | +$21.4K |
|
|
MM
3294
DELISTED
MILLENNIAL MEDIA INC COM STK (DE)
MM
| $2.61M | ﹤0.01% |
1,802,797
+108,277
| +6% | +$165K |
|
3295
Trupanion
TRUP
$1.23B
| $2.61M | ﹤0.01% |
326,419
+221,210
| +210% | +$1.68M |
|
|
ADMS
3296
DELISTED
Adamas Pharmaceuticals
ADMS
| $2.61M | ﹤0.01% |
149,161
+49,884
| +50% | +$855K |
|
3297
Southern First Bancshares
SFST
$604M
| $2.61M | ﹤0.01% |
153,406
+82,267
| +116% | +$1.41M |
|
|
BTH
3298
DELISTED
BLYTH,INC
BTH
| $2.59M | ﹤0.01% |
341,349
+6,960
| +2% | +$54.4K |
|
|
ITIC
3299
Investors Title Co
ITIC
$558M
| $2.59M | ﹤0.01% |
34,962
+1,000
| +3% | +$72.4K |
|
|
FSGI
3300
DELISTED
FIRST SECURITY GROUP, INC.
FSGI
| $2.58M | ﹤0.01% |
1,076,178
+11,000
| +1% | +$24.8K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.